| [1] |
曹京旭.靶性放射性核素治疗骨转移[J].国外医学·放射医学核医学分册, 1995, 19(4):153~156.
|
| [2] |
Cameron PS, Klemp PF, Martindale AA, et al. Pro-spective 153Sm-EDTMP therapy dosimetry by whole body scintigraphy[J]. Nucl Med Commun, 1999, 20(7):609~615.
|
| [3] |
Friedland J. Local and systemic radiation for palliation of metastatic disease[J]. Urol Clin North Am, 1999,26(2):391~402.
|
| [4] |
金稚奎. 骨转移瘤的放射性核素治疗[J].国外医学·放射医学核医学分册, 1995, 19(4):145~148.
|
| [5] |
Quirijnen JM, Han SH, Zonnenberg BA, et al.Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pine[J]. J Nucl Med,1996, 37(9):1511~1515.
|
| [6] |
Limouris GS, Shukla SK, Condi PA, et al. Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases[J]. Anticancer Res, 1997, 17(3B):1767~1779.
|
| [7] |
Palmedo H, Bender H, Schomburg A, et al. Pain therapy with rhenium-186-HEDP in multiple bone metastases[J]. J Nucl Med, 1996, 35(2):63~67.
|
| [8] |
de Klerk JMH, van het Schip AD, Zonnenherg BA, et al. Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer[J]. J Nucl Med, 1996, 37(1):38~41.
|
| [9] |
Lin WY, Lin CP,Yeh SJ, et al. Rhenium-188 hydroxyethylidene diphosphonate:a. new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases[J]. Eur J Nucl Med, 1997, 24(6):590~595.
|
| [10] |
林祥通.关于放射性核素治疗骨转移所致疼痛的疗效评价[J].中华核医学杂志, 1995, 15(2):123.
|